Mariana Baz Etchebarne

Silveira F, Rivera-Patron M, Deshpande N, Sienra S, Checa J, Moreno M, Chabalgoity JA, Cibulski SP, Baz M

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

Front Immunol, 14 , 2023.

Résumé | Liens:

Panzera Y, Mirazo S, Baz M, Techera C, Grecco S, Cancela F, Fuques E, Condon E, Calleros L, Camilo N, Fregossi A, Vaz I, Pessina P, Deshpande N, Pérez R, Benech A

Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patients

Mem Inst Oswaldo Cruz, 117 , 2023.

Résumé | Liens:

Nantel S, Bourdin B, Adams K, Carbonneau J, Rabezanahary H, Hamelin MÈ, McCormack D, Savard P, Longtin Y, Cheng MP, De Serres G, Corbeil J, Gilca V, Baz M, Boivin G, Quach C, Decaluwe H

Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine

Front Immunol, 13 , 2022.

Résumé | Liens:

Rabezanahary H, Badr A, Checkmahomed L, Pageau K, Desjardins Y, Baz M

Epigallocatechin Gallate and Isoquercetin Synergize With Remdesivir to Reduce SARS-CoV-2 Replication In Vitro

Front Virol, 2 , 2022.

Résumé | Liens:

Baz M, Deshpande N, Mackenzie-Kludas C, Mordant F, Anderson D, Subbarao K

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice

Emerg Infect Dis, 28 (11), 2022.

Résumé | Liens:

O'Neill G, Aziz A, Kuba M, Brown SK, Lau H, Soppe S, Baz M, Peck H, Deng YM, Subbarao K, Barr IG

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021

Commun Dis Intell (2018), 46 , 2022.

Résumé | Liens:

Pedersen J, Koumakpayi IH, Babuadze G, Baz M, Ndiaye O, Faye O, Diagne CT, Dia N, Naghibosadat M, McGeer A, Muberaka S, Moukandja IP, Ndidi S, Tauil CB, Lekana-Douki JB, Loucoubar C, Sall A, Magalhães KG, Weis N, Kozak R, Kobinger GP, Fausther-Bovendo H

Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic

Sci Rep, 12 (1), 2022.

Résumé | Liens:

Olivera-Ugarte SM, Bolduc M, Laliberté-Gagné MÈ, Blanchette LJ, Garneau C, Fillion M, Savard P, Dubuc I, Flamand L, Farnòs O, Xu X, Kamen A, Gilbert M, Rabezanahary H, Scarrone M, Couture C, Baz M, Leclerc D

A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection

Nanomedicine, 44 , 2022.

Résumé | Liens:

Söderlund-Venermo M, Varma A, Guo D, Gladue DP, Poole E, Pujol FH, Pappu H, Romalde JL, Kramer L, Baz M, Venter M, Moore MD, Nevels MM, Ezzikouri S, Vakharia VN, Wilson WC, Malik YS, Shi Z, Abdel-Moneim AS

World Society for Virology first international conference: Tackling global virus epidemics

Virology, 566 , 2022.

Résumé | Liens:

Brown SK, Tseng YY, Aziz A, Baz M, Barr IG

Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors

Antiviral Res, 200 , 2022.

Résumé | Liens: